What is the most recent earnings date for DIM stock?
SARTORIUS STEDIM BIOTECH (DIM.PA) last reported earnings on 2/3/2026.
EPA:DIM • FR0013154002
Past quarterly earnings results for SARTORIUS STEDIM BIOTECH (DIM.PA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.12 | 1.28 | -12.72% | 8.74% | 772.2M | 805.83M | -4.17% | 2.78% |
| Q3 2025 | 0.94 | 0.96 | -2.24% | 23.68% | 705.7M | 734.65M | -3.94% | 7.67% |
| Q2 2025 | 1.18 | 1.07 | 10.22% | 38.82% | 745M | 742.74M | 0.30% | 5.46% |
| Q1 2025 | 1.16 | 0.95 | 22.18% | 34.88% | 744.6M | 719.3M | 3.52% | 11.65% |
| Q4 2024 | 1.03 | 0.96 | 7.63% | 43.06% | 751.3M | 730.06M | 2.91% | 6.30% |
| Q3 2024 | 0.76 | 0.81 | -5.62% | -10.59% | 655.4M | 690.73M | -5.11% | -1.72% |
| Q2 2024 | 0.85 | 1.07 | -20.27% | -28.57% | 706.4M | 696.1M | 1.48% | 4.54% |
| Q1 2024 | 0.86 | 0.95 | -9.42% | -39.86% | 666.9M | 726.14M | -8.16% | -8.15% |
| Q4 2023 | 0.72 | 0.85 | -15.13% | -65.05% | 706.8M | 659.45M | 7.18% | -20.58% |
| Q3 2023 | 0.85 | 2.81 | -69.78% | -61.01% | 666.9M | 723.67M | -7.84% | -24.08% |
| Q2 2023 | 1.19 | 2.15 | -44.76% | -45.66% | 675.7M | 709.53M | -4.77% | -21.59% |
| Q1 2023 | 1.43 | 1.44 | -0.76% | -35.29% | 726.1M | 733.36M | -0.99% | -15.81% |
| Q4 2022 | 2.06 | 2.17 | -5.05% | 6.19% | 890M | 917.58M | -3.01% | 14.37% |
| Q3 2022 | 2.18 | 3.05 | -28.54% | 7.39% | 878.4M | 906.82M | -3.13% | -58.35% |
| Q2 2022 | 2.19 | 3.27 | -33.08% | 18.38% | 861.8M | 883.44M | -2.45% | 23.70% |
| Q1 2022 | 2.21 | 2.79 | -20.84% | 34.76% | 862.5M | 787.82M | 9.48% | 31.64% |
| Q4 2021 | 1.94 | 1.83 | 5.83% | 70.18% | 778.177M | 755.82M | 2.96% | 46.64% |
| Q3 2021 | 2.03 | 1.85 | 9.83% | 69.17% | 2.109B | 703.67M | 199.69% | 313.17% |
| Q2 2021 | 1.85 | 1.57 | 18.17% | 94.74% | 696.7M | 670.5M | 3.91% | 55.86% |
| Q1 2021 | 1.64 | 1.46 | 11.98% | 88.51% | 655.2M | 584.79M | 12.04% | 55.22% |
| Q4 2020 | 1.14 | 1.09 | 4.70% | - | 530.681M | 490.04M | 8.29% | - |
| Q3 2020 | 1.20 | 0.95 | 25.73% | - | 510.4M | 456.85M | 11.72% | - |
| Q2 2020 | 0.95 | 0.91 | 4.28% | - | 447M | 454.6M | -1.67% | - |
| Q1 2020 | 0.87 | 0.77 | 13.71% | - | 422.1M | 403.42M | 4.63% | - |
Notes
SARTORIUS STEDIM BIOTECH (DIM.PA) last reported earnings on 2/3/2026.
SARTORIUS STEDIM BIOTECH (DIM.PA) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, SARTORIUS STEDIM BIOTECH (DIM.PA) has beaten EPS estimates in 2 out of 4 releases.